Drug Conjugated and Bispecific Antibodies for Multiple Myeloma: Improving Immunotherapies off the Shelf

The spectacular enchancment of total survival in a number of myeloma (MM) sufferers within the final years has been largely associated to the supply of latest lessons of medicine with totally different mechanisms of motion, together with proteasome inhibitors (PI), immunomodulating brokers (IMiDs), and monoclonal antibodies. Nevertheless, even with this elevated potence of fireplace, MM nonetheless stays an incurable situation, as a consequence of clonal choice and evolution of neoplastic clone. This idea underlines the significance of immunotherapy as one of the crucial related instruments to attempt to eradicate the illness.

In keeping with this idea, energetic and passive immunotherapies characterize essentially the most enticing strategy to this intention. Antibody-drug conjugate(s) (ADCs) and bispecific antibodies (BsAbs) embody two progressive instruments in an effort to restrict neoplastic plasma cell development and even, if used on the time of one of the best response, to doubtlessly eradicate the tumoral clone. Following their promising outcomes as single agent for superior illness, on the latest 62nd ASH assembly, encouraging knowledge of a number of combos, notably of ADC(s) with PI or IMiDs, have been reported, suggesting even higher outcomes for sufferers handled earlier. On this paper, we reviewed the traits, mechanism of motion, and scientific knowledge accessible for many related ADC(s) and BsAbs.

Interspecies Scaling of Antibody-Drug Conjugates (ADC) for the Prediction of Human Clearance

Allometric scaling is a useful gizmo for the extrapolation of pharmacokinetic parameters from animals to people. The target of this research was to foretell human clearance of antibody-drug conjugates (ADC) allometrically from one to a few animal species and evaluate the anticipated human clearance with the noticed human clearance. For 3 animal species allometric scaling, the “Rule of Exponents” (ROE) was used. The outcomes of the research indicated that three-species allometric scaling in affiliation with the ROE supplies acceptable prediction (inside 0.5-2-fold prediction error) of human clearance.
The 2-species allometric scaling resulted in substantial prediction error. One-species scaling utilizing a hard and fast exponent of 1.Zero offered acceptable prediction error (inside 0.5-2-fold) by monkey, rat, and mouse, through which monkey and rat have been comparable. General, the anticipated human clearance values of ADCs from animal(s) was good. The allometric methodology proposed on this article can be utilized to foretell human clearance from the animal knowledge and subsequently to pick the first-in-human dose of ADCs.

Expeditious Era of Biparatopic Widespread Gentle Chain Antibodies through Rooster Immunization and Yeast Show Screening

Bispecific (BsAb) and biparatopic (BpAb) antibodies emerged as promising codecs for therapeutic biologics exhibiting tailored purposeful properties. Over latest years, chicken-derived antibodies have gained traction for diagnostic and therapeutic functions as a consequence of their broad epitope protection and comfort of library era. Right here we report the primary era of a biparatopic frequent gentle chain (cLC) chicken-derived antibody by an epitope binning-based screening strategy utilizing yeast floor show.
Drug Conjugated and Bispecific Antibodies for Multiple Myeloma: Improving Immunotherapies off the Shelf
The ensuing monospecific antibodies goal conformational epitopes on area II or III of the epidermal development issue receptor (EGFR) with decrease double- or single-digit nanomolar affinities, respectively. Moreover, the area III concentrating on variant was proven to intrude with epidermal development issue (EGF) binding. Using the Knob-into-Gap expertise (KiH), a biparatopic antibody with subnanomolar affinity was generated that facilitates clustering of soluble and cell-bound EGFR and displayed enhanced antibody-dependent cell-mediated cytotoxicity (ADCC) in comparison with the parental antibodies. This technique for producing cLC-based biparatopic antibodies from immunized chickens might pave the way in which for his or her additional improvement in therapeutic settings.

Glycoengineering of AAV-delivered monoclonal antibodies yields elevated ADCC exercise

The absence of fucose on asparagine-297 of the human immunoglobulin G (IgG) heavy chain has been proven to reinforce antibody-dependent mobile cytotoxicity (ADCC) exercise by 10- to 100-fold in comparison with fucosylated antibody. Our lab is learning using adeno-associated virus (AAV) as a vector for the supply of HIV-specific antibodies for therapeutic functions. For the reason that antibody is produced by vector-transduced cells in vivo, present methods of glycoengineering can’t be utilized. As a way to obtain comparable enhancement of ADCC with AAV-delivered antibodies, brief hairpin RNAs (shRNAs) that focus on fucosyltransferase-8 (FUT8), have been designed, examined, and cloned into AAV vectors used to ship HIV-specific broadly neutralizing antibodies (bNAbs).
Antibodies produced by our glycoengineered-AAV (GE-AAV) vectors have been analyzed for fucose content material and ADCC. GE-AAV constructs have been capable of obtain over 80% knockdown of FUT8. Outcomes have been confirmed by lectin western blot for α1-6 fucose, which revealed virtually an entire absence of fucose on GE-AAV-produced antibodies. GE-AAV-produced antibodies revealed >10-fold enhancement of ADCC, whereas exhibiting similar neutralization and gp140 trimer binding in comparison with their fucosylated counterparts.

IL-1 R2 (Human) Sandwich ELISA Kit

OK-0229 1Kit
EUR 280
Description: IL-1 R2 (Human) Colorimetric Sandwich ELISA Kit

IL-1 R2 (Human) OmniKine ELISA Kit

MBS9501955-1x96Wells 1x96Wells
EUR 500

IL-1 R2 (Human) OmniKine ELISA Kit

MBS9501955-5x96Wells 5x96Wells
EUR 2300

IL-1 R2 ELISA Kit (Human) : 96 Wells (OKAG00129)

OKAG00129 96 Wells
EUR 715.2
Description: Description of target: The protein encoded by this gene is a cytokine receptor that belongs to the interleukin 1 receptor family. This protein binds interleukin alpha (IL1A), interleukin beta (IL1B), and interleukin 1 receptor, type I(IL1R1/IL1RA), and acts as a decoy receptor that inhibits the activity of its ligands. Interleukin 4 (IL4) is reported to antagonize the activity of interleukin 1 by inducing the expression and release of this cytokine. This gene and three other genes form a cytokine receptor gene cluster on chromosome 2q12. Alternative splicing results in multiple transcript variants and protein isoforms. Alternative splicing produces both membrane-bound and soluble proteins. A soluble protein is also produced by proteolytic cleavage.;Species reactivity: Human;Application: ELISA;Assay info: Quantitative Colorimentric Sandwich ELISA;Sensitivity: 32 pg/mL

IL 1 R2 Recombinant Protein

96-436 0.1 mg
EUR 619.8
Description: Interleukin-1 receptor type 2 (IL1R2) is also known as CD121 antigen-like family member B (CDw121b), IL-1 type II receptor, Interleukin-1 receptor type II, belongs to the interleukin-1 receptor family. Two distinct types of IL1 receptors which are able to bind IL1 specifically have been identified, designated as IL1RI (IL1RA) and IL1RII (IL1RB). IL1R2 is non-signaling receptor for IL1A, IL1B and IL1RN, reduces IL1B activities. Serves as a decoy receptor by competetive binding to IL1B and preventing its binding to IL1R1. IL1R2 modulates cellular response through non-signaling association with IL1RAP after binding to IL1B. IL1R2 (membrane and secreted forms) preferentially binds IL1B and poorly IL1A and IL1RN. The secreted IL1R2 recruits secreted IL1RAP with high affinity; this complex formation may be the dominant mechanism for neutralization of IL1B by secreted/soluble receptors.

Mouse Anti Human IL-1 beta

MBS140161-05mg 0.5mg
EUR 440

Mouse Anti Human IL-1 beta

MBS140161-1mg 1mg
EUR 600

Mouse Anti Human IL-1 beta

MBS140161-5x1mg 5x1mg
EUR 2375

Recombinant Mouse IL-1 R2/IL-1 RII Protein

RP00726 10μg
EUR 138.16

Recombinant Mouse IL-1 R2/IL-1 RII Protein

RP00729 10μg
EUR 138.16

Anti‐Human IL‐17A

E2790213 100ul
EUR 225
Description: Available in various conjugation types.

Mouse Anti Human IL-1 beta FITC

MBS140163-05mg 0.5mg
EUR 440

Mouse Anti Human IL-1 beta FITC

MBS140163-1mg 1mg
EUR 600

Mouse Anti Human IL-1 beta FITC

MBS140163-5x1mg 5x1mg
EUR 2375

human anti-human IL-1 β mAb(14)

E4A09D02-14 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

human anti-human IL-1 β mAb(7Z)

E4A09D02-7Z 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

Monoclonal Mouse anti Human IL-1 beta

MBS550073-05mg 0.5mg
EUR 595

Monoclonal Mouse anti Human IL-1 beta

MBS550073-1mg 1mg
EUR 915

Mouse Anti Human IL-1 beta Biotinylated

MBS140162-05mg 0.5mg
EUR 440

Mouse Anti Human IL-1 beta Biotinylated

MBS140162-1mg 1mg
EUR 600

Mouse Anti Human IL-1 beta Biotinylated

MBS140162-5x1mg 5x1mg
EUR 2375

TNF-R2 (human)

TN-004 50 µg
EUR 738

anti-PKA R2

YF-PA24454 50 ul
EUR 400.8
Description: Mouse polyclonal to PKA R2

anti-PKA R2

YF-PA13990 50 ul
EUR 435.6
Description: Mouse polyclonal to PKA R2

human anti-human IL-2 mAb

E409C12-h100 100μL
EUR 395
Description: Available in various conjugation types.

human anti-human IL-4 mAb

E409C13-h100 100μL
EUR 395
Description: Available in various conjugation types.

human anti-human IL-5 mAb

E409C14-h100 100μL
EUR 395
Description: Available in various conjugation types.

human anti-human IL-8 mAb

E409C16-h100 100μL
EUR 395
Description: Available in various conjugation types.

human anti-human IL-5 mAb

E4A09D05 50ug
EUR 255
Description: Available in various conjugation types.

Human anti-Human IL-2 mAb

MBS8576800-005mg 0.05mg
EUR 325

Human anti-Human IL-2 mAb

MBS8576800-01mLAF405L 0.1mL(AF405L)
EUR 565

Human anti-Human IL-2 mAb

MBS8576800-01mLAF405S 0.1mL(AF405S)
EUR 565

Human anti-Human IL-2 mAb

MBS8576800-01mLAF610 0.1mL(AF610)
EUR 565

Human anti-Human IL-2 mAb

MBS8576800-01mLAF635 0.1mL(AF635)
EUR 565

Human anti-Human IL-4 mAb

MBS8576802-005mg 0.05mg
EUR 325

Human anti-Human IL-4 mAb

MBS8576802-01mLAF405L 0.1mL(AF405L)
EUR 565

Human anti-Human IL-4 mAb

MBS8576802-01mLAF405S 0.1mL(AF405S)
EUR 565

Human anti-Human IL-4 mAb

MBS8576802-01mLAF610 0.1mL(AF610)
EUR 565

Human anti-Human IL-4 mAb

MBS8576802-01mLAF635 0.1mL(AF635)
EUR 565

Human anti-Human IL-5 mAb

MBS8576804-005mg 0.05mg
EUR 325

Human anti-Human IL-5 mAb

MBS8576804-01mLAF405L 0.1mL(AF405L)
EUR 565

Human anti-Human IL-5 mAb

MBS8576804-01mLAF405S 0.1mL(AF405S)
EUR 565

Human anti-Human IL-5 mAb

MBS8576804-01mLAF610 0.1mL(AF610)
EUR 565

Human anti-Human IL-5 mAb

MBS8576804-01mLAF635 0.1mL(AF635)
EUR 565

Human anti-Human IL-8 mAb

MBS8576808-005mg 0.05mg
EUR 325

Human anti-Human IL-8 mAb

MBS8576808-01mLAF405L 0.1mL(AF405L)
EUR 565

Human anti-Human IL-8 mAb

MBS8576808-01mLAF405S 0.1mL(AF405S)
EUR 565

Human anti-Human IL-8 mAb

MBS8576808-01mLAF610 0.1mL(AF610)
EUR 565

Human anti-Human IL-8 mAb

MBS8576808-01mLAF635 0.1mL(AF635)
EUR 565

human anti-human IL-1β mAb

E409C11-h100 100μL
EUR 395
Description: Available in various conjugation types.

human anti-human IL-10 mAb

E409C17-h100 100μL
EUR 395
Description: Available in various conjugation types.

Human anti-Human IL-10 mAb

MBS8576810-005mg 0.05mg
EUR 325

Human anti-Human IL-10 mAb

MBS8576810-01mLAF405L 0.1mL(AF405L)
EUR 565

Human anti-Human IL-10 mAb

MBS8576810-01mLAF405S 0.1mL(AF405S)
EUR 565

Human anti-Human IL-10 mAb

MBS8576810-01mLAF610 0.1mL(AF610)
EUR 565

Human anti-Human IL-10 mAb

MBS8576810-01mLAF635 0.1mL(AF635)
EUR 565

human anti-human IL-17A mAb

E409C18-h100 100μL
EUR 276.5
Description: Inflammation Storm Antibodies

Human anti-Human IL-1beta mAb

MBS8576798-005mg 0.05mg
EUR 325

Human anti-Human IL-1beta mAb

MBS8576798-01mLAF405L 0.1mL(AF405L)
EUR 565

Human anti-Human IL-1beta mAb

MBS8576798-01mLAF405S 0.1mL(AF405S)
EUR 565

Human anti-Human IL-1beta mAb

MBS8576798-01mLAF610 0.1mL(AF610)
EUR 565

Human anti-Human IL-1beta mAb

MBS8576798-01mLAF635 0.1mL(AF635)
EUR 565

human anti-human IL-12/IL-23 p40 mAb(3H2)

E4A09D33-3H2 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

human anti-human IL-12/IL-23 p40 mAb(5N9)

E4A09D33-5N9 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

Human anti-human IL-12/IL-23 p40 mAb (3H2)

A09D33-3H2 1 Each Ask for price

Human anti-human IL-12/IL-23 p40 mAb (5N9)

A09D33-5N9 1 Each Ask for price

human anti-human IL-12/IL-23 p40 mAb(1G11)

E4A09D33-1G11 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

Human anti-human IL-12/IL-23 p40 mAb (1G11)

A09D33-1G11 1 Each Ask for price

Human VEGF R2/FLK-1 ELISA Kit

SEKH-0339
  • Ask for price
  • Ask for price
  • 48 Tests
  • 96 Tests

ApoE R2, Recombinant Human

MBS636329-005mg 0.05mg
EUR 880

ApoE R2, Recombinant Human

MBS636329-5x005mg 5x0.05mg
EUR 3730

Anti-Human TGF beta R2 Antibody

101-M178 100 µg
EUR 399
Description: Most cell types express three sizes of receptors for TGF-beta. These are designated Type I (53 kDa), Type II (70 - 85 kDa), and Type III (250 - 350 kDa). The Type I receptor is a membrane-bound serine/threonine kinase that apparently requires the presence of the Type II receptor to bind TGF-beta. The Type II receptor is also a membrane-bound serine/threonine kinase that binds TGF-beta1 and TGF-beta 3 with high affinity and TGF-beta 2 with much lower affinity. The Type I and Type II receptors together form a heterodimeric signaling complex that is essential for the transduction of the anti-proliferative signals of TGF-beta. The Type III receptor is a transmembrane proteoglycan with a large extracellular domain and a 43 amino acid residue cytoplasmic domain. The cytoplasmic domain of the Type III receptor lacks an obvious signaling motif and the receptor may not be involved directly in signal transduction.

Mouse anti Human IL-1RAcP/IL-1R3 Monoclonal Antibody

MBS2543245-006mL 0.06mL
EUR 250

Mouse anti Human IL-1RAcP/IL-1R3 Monoclonal Antibody

MBS2543245-012mL 0.12mL
EUR 370

Mouse anti Human IL-1RAcP/IL-1R3 Monoclonal Antibody

MBS2543245-02mL 0.2mL
EUR 550

Mouse anti Human IL-1RAcP/IL-1R3 Monoclonal Antibody

MBS2543246-006mL 0.06mL
EUR 250

Mouse anti Human IL-1RAcP/IL-1R3 Monoclonal Antibody

MBS2543246-012mL 0.12mL
EUR 370

Mouse anti Human IL-1RAcP/IL-1R3 Monoclonal Antibody

MBS2543246-02mL 0.2mL
EUR 550

Mouse Monoclonal anti-human FGF-R2

hAP-0278 100ug
EUR 250

Mouse Monoclonal anti-human FGF-R2

hAP-0278A 100ug
EUR 250

Mouse Monoclonal anti-human Orexin R2

hAP-0850 50ug
EUR 400

MOUSE ANTI HUMAN CD126 (IL-6R)

MBS213171-01mg 0.1mg
EUR 355

MOUSE ANTI HUMAN CD126 (IL-6R)

MBS213171-5x01mg 5x0.1mg
EUR 1425

human anti-human IL-2 mAb(1H)

E409C12-hA100 Inflammation-Storm-Antibodies
EUR 276.5
Description: Inflammation Storm Antibodies

human anti-human IL-2 mAb(2H)

E409C12-hB100 Inflammation-Storm-Antibodies
EUR 276.5
Description: Inflammation Storm Antibodies

human anti-human IL-8 mAb(1H)

E409C16-hA100 Inflammation-Storm-Antibodies
EUR 276.5
Description: Inflammation Storm Antibodies

human anti-human IL-8 mAb(2H)

E409C16-hB100 Inflammation-Storm-Antibodies
EUR 276.5
Description: Inflammation Storm Antibodies

human anti-human IL-2 mAb(D1)

E4A09D03-A7C 50ug
EUR 255
Description: Available in various conjugation types.

human anti-human IL-2 mAb(F5)

E4A09D03-B1F 50ug
EUR 255
Description: Available in various conjugation types.

human anti-human IL-2 mAb(16)

E4A09D03-C3C 50ug
EUR 255
Description: Available in various conjugation types.

human anti-human IL-4 mAb(12)

E4A09D04-12 50ug
EUR 255
Description: Available in various conjugation types.

human anti-human IL-4 mAb(52)

E4A09D04-52 50ug
EUR 255
Description: Available in various conjugation types.

human anti-human IL-4 mAb(C1)

E4A09D04-C1 50ug
EUR 255
Description: Available in various conjugation types.

human anti-human IL-6 mAb(A3)

E4A09D06-hA3 50ug
EUR 255
Description: Available in various conjugation types.

human anti-human IL-8 mAb(1F)

E4A09D07-1F 100ug
EUR 595

human anti-human IL-8 mAb(A5)

E4A09D07-A5A 50ug
EUR 255
Description: Available in various conjugation types.

human anti-human IL-8 mAb(6G)

E4A09D07-B5G 50ug
EUR 255
Description: Available in various conjugation types.

human anti-human IL-8 mAb(AB)

E4A09D07-C8A 50ug
EUR 255
Description: Available in various conjugation types.

human anti-human IL-8 mAb(N2)

E4A09D07-N2 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

human anti-human IL-8 mAb(N8)

E4A09D07-N8 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

Human anti-human IL-2 mAb (D1)

A09D03-A7C 1 Each Ask for price

Human anti-human IL-2 mAb (F5)

A09D03-B1F 1 Each Ask for price

Human anti-human IL-2 mAb (16)

A09D03-C3C 1 Each Ask for price

Human anti-human IL-4 mAb (C1)

A09D04-C1 1 Each Ask for price

Human anti-human IL-8 mAb (1F)

A09D07-1F 1 Each Ask for price

Human anti-human IL-8 mAb (A5)

A09D07-A5A 1 Each Ask for price

Human anti-human IL-8 mAb (6G)

A09D07-B5G 1 Each Ask for price

Human anti-human IL-8 mAb (AB)

A09D07-C8A 1 Each Ask for price

Human anti-human IL-8 mAb (N2)

A09D07-N2 1 Each Ask for price

Human anti-human IL-8 mAb (N8)

A09D07-N8 1 Each Ask for price

human anti-human IL-1β mAb(1H)

E409C11-hA100 Inflammation-Storm-Antibodies
EUR 276.5
Description: Inflammation Storm Antibodies

human anti-human IL-1β mAb(2H)

E409C11-hB100 Inflammation-Storm-Antibodies
EUR 276.5
Description: Inflammation Storm Antibodies

human anti-human IL-10 mAb(1H)

E409C17-hA100 Inflammation-Storm-Antibodies
EUR 276.5
Description: Inflammation Storm Antibodies

human anti-human IL-10 mAb(2H)

E409C17-hB100 Inflammation-Storm-Antibodies
EUR 276.5
Description: Inflammation Storm Antibodies

human anti-human IL-1β mAb(95)

E4A09D02-h9 50ug
EUR 255
Description: Available in various conjugation types.

human anti-human IL-1β mAb(Ca)

E4A09D02-hA 50ug
EUR 255
Description: Available in various conjugation types.

human anti-human IL-1β mAb(Ge)

E4A09D02-hB 50ug
EUR 255
Description: Available in various conjugation types.

human anti-human IL-5 mAb(E10)

E4A09D05-E10 100ug
EUR 595

human anti-human IL-5 mAb(Q12)

E4A09D05-Q12 100ug
EUR 595

human anti-human IL-6 mAb(10C)

E4A09D06-h10C 50ug
EUR 255
Description: Available in various conjugation types.

human anti-human IL-6 mAb(2D2)

E4A09D06-hD2 50ug
EUR 255
Description: Available in various conjugation types.

human anti-human IL-10 mAb(97)

E4A09D08-A9D 50ug
EUR 255
Description: Available in various conjugation types.

human anti-human IL-10 mAb(18)

E4A09D08-B2G 50ug
EUR 255
Description: Available in various conjugation types.

human anti-human IL-15 mAb(1A)

E4A09D21-1A 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

human anti-human IL-15 mAb(2B)

E4A09D21-2B 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

human anti-human IL-15 mAb(7C)

E4A09D21-7C 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody
ADCC was enhanced 40- to 60-fold when mixed with key Fc mutations recognized to reinforce binding to FcγRIIIA. Our findings outline a robust strategy for supercharging AAV-delivered anti-HIV antibodies.

 

 

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *